Skip to content

PolitiKit

Laetitia Decroix Guilloux's lobbying: the registrations they file and every meeting they've reported since November 2021.

← Lobbying

Registrant (responsible officer)

Laetitia Decroix Guilloux

President

For companies and organizations, the most senior paid officer files the registration and the monthly reports, whoever attended the meeting.

Meetings this Parliament
8
Since Nov 2021
8
Active registrations
1

Reported meetings

  • Janssen Inc.
    • Justine Frame · Senior Policy Advisor, Health Canada (HC)
    Communications regarding the maintenance of domestic supply of essential drug products.

    Official report

  • Janssen Inc.
    • Ritu Banerjee · Assistant Deputy Minister, Health Emergency Readiness Canada, Innovation, Science and Economic Development Canada (ISED)
    Development of Health Emergency Readiness Canada agency, and role in promoting development life sciences sector. Read more

    Incentives and programs to attract and support manufacturing activities in Canada

    Official report

  • Janssen Inc.
    Canada's Innovation Agenda: ensuring that the life sciences industry is included and promoting awareness of and support for the full ecosystem from early stage research to commercialization and reimbursement. Read more

    Official report

  • Janssen Inc.
    • Ritu Banerjee · Assistant Deputy Minister, Innovation, Science and Economic Development Canada (ISED)
    • Michelle Boudreau · Associate Assistant Deputy Minister, Health Canada (HC)
    Canada's Innovation Agenda: ensuring that the life sciences industry is included and promoting awareness of and support for the full ecosystem from early stage research to commercialization and reimbursement. Read more

    Official report

  • Janssen Inc.
    • Ritu Banerjee · Assistant Deputy Minister, Innovation, Science and Economic Development Canada (ISED)
    • Michelle Boudreau · Associate Assistant Deputy Minister, Health Canada (HC)
    Canada's Innovation Agenda: ensuring that the life sciences industry is included and promoting awareness of and support for the full ecosystem from early stage research to commercialization and reimbursement. Read more

    Official report

  • Janssen Inc.
    • Ritu Banerjee · Assistant Deputy Minister, Innovation, Science and Economic Development Canada (ISED)
    • Michelle Boudreau · Associate Assistant Deputy Minister, Health Canada (HC)
    Canada's Innovation Agenda: ensuring that the life sciences industry is included and promoting awareness of and support for the full ecosystem from early stage research to commercialization and reimbursement. Read more

    Official report

  • Janssen Inc.
    • Dominic LeBlanc · President of the King's Privy Council for Canada and Minister of International Trade and Intergovernmental Affairs, Privy Council Office (PCO)
    • Karim Bardeesy · Parliamentary Secretary to the Minister of Industry, Innovation, Science and Economic Development Canada (ISED)
    • Marjorie Michel · Minister, Health Canada (HC)
    • Nasser Haidar · Senior Policy Advisor, Privy Council Office (PCO)
    and 7 more
    • Janice Charette · Chief Trade Negotiator to the United States, Privy Council Office (PCO)
    • Martin Moen · Associate Assistant Deputy Minister, Trade Policy and Negotiations, Global Affairs Canada (GAC)
    • Ritu Banerjee · Assistant Deputy Minister, Innovation, Science and Economic Development Canada (ISED)
    • Manuela Tomic · Senior Policy Advisor, Office of the Minister of Industry, Innovation, Science and Economic Development Canada (ISED)
    • Justine Frame · Policy Advisor, Minister’s Office, Health Canada (HC)
    • Sandenga Yeba · Deputy Chief of Staff and Director of Policy to the Minister, Health Canada (HC)
    • Shalene Curtis-Micallef · Deputy Minister, Health Canada (HC)
    Canadian Drug Agency: the mandate and creation of a new Canadian Drug Agency and transition work to support pharmacare-related initiatives, including patient access and reimbursement framework. Read more

    Canada-United States-Mexico Agreement (CUSMA) and pharmaceutical intellectual property protection.

    Incentives and programs to attract and support manufacturing activities in Canada

    Development of Health Emergency Readiness Canada agency, and role in promoting development life sciences sector.

    Official report

  • Janssen Inc.
    • Justine Frame · Policy Advisor, Minister’s Office, Health Canada (HC)
    Communications regarding Canada’s mental health strategy, implementation and access to services for Canadians.

    Official report

From the Office of the Commissioner of Lobbying's open data, published November 5, 2026. Reports cover oral, arranged meetings with designated public office holders since November 22, 2021; lobbyists file them by the 15th of the following month. Names of MPs are matched to the current House of Commons, and bills are linked when the lobbyist's own description makes clear which bill it means. Contains information licensed under the Open Data Licence Agreement — Office of the Commissioner of Lobbying. Licence. PolitiKit is independent and is not endorsed by the Commissioner of Lobbying.